The reiteration of an Outperform rating and the maintenance of a high price target by a reputable analyst like Gregory Renza could positively influence investor sentiment towards Amgen. This endorsement suggests confidence in Amgen's future performance, potentially leading to an uptick in its stock price in the short term.